Capital Signal
Cambridge, UK
Series A closed — Cambridge Therapeutics raises $45M for neuro-regeneration platform.
Capital · $45.0M2m ago
Building the future of
Global Life Science Entrepreneurship
An internationally distinctive platform connecting top-tier founders, scientists, and investors within a sovereign-wealth-grade ecosystem. Discovery to commercialization, in one place.
Verified credentials AI matchmaking
The Architecture
A complete architecture for Institutional Commercialization
Every stage of the bioeconomy — from a discovery on a lab bench to a global biotech company — operating under one sovereign-grade standard.
01
AI Startup Builder
Turn research, theses & datasets into investable startups with full business models and pitch decks.
Enter ecosystem →
02
Global Networking
A directory-grade ecosystem for founders, scientists, investors and universities.
Enter ecosystem →
03
Mentorship Platform
AI-matched mentors, advisory boards and 1:1 video sessions across the globe.
Enter ecosystem →
04
Funding Infrastructure
Grant database, investor discovery, valuation tools and AI matchmaking.
Enter ecosystem →
05
Bioeconomy Academy
Founder challenges, simulations and certified paths in biotech entrepreneurship.
Enter ecosystem →
06
Research Commercialization
Patent analysis, licensing, TRL scoring and research-to-market pipelines.
Enter ecosystem →
07
Ecosystem Intelligence
Country rankings, heatmaps and AI predictions on innovation flows.
Enter ecosystem →
08
International Collaboration
Cross-border teams, hackathons and scientific diplomacy networks.
Enter ecosystem →
09
Freelance Marketplace
Bioinformatics, genomics, regulatory and grant-writing specialists on demand.
Enter ecosystem →
10
Remote Lab Marketplace
Sequencing, cloud labs, compute and AI experimental design at your fingertips.
Enter ecosystem →
11
Regional Hubs
Dedicated ecosystems for Africa, MENA, Asia, Europe, LATAM and North America.
Enter ecosystem →
12
BioGrowth AI Copilot
Your always-on partner — recommends grants, mentors, collaborators and strategy.
Enter ecosystem →
13
Community & Content
Founder stories, journals, podcasts, webinars and biotech news feed.
Enter ecosystem →
14
Government & University
Enterprise dashboards for ministries, incubators, accelerators and universities.
Enter ecosystem →
15
Admin & Compliance
Moderation, subscriptions, funding tracking and full platform analytics.
Enter ecosystem →
16
Premium Monetization
Subscriptions, accelerator memberships, marketplace commissions and AI tools.
Enter ecosystem →
The Intelligence
The global biotech signal
Real-time capital flows, regulatory milestones, and breakthrough research across the BioGrowth node network — curated by region, stage, and therapeutic area.
Access Terminal12k
Signals / mo
84
Sources
32
Countries
Regulatory Signal
EMA · Brussels
EMA fast-track designation granted for BioGrowth Portfolio member #G90-44.
Phase II Clear14m ago
Network Signal
Singapore
NUS Enterprise joins BioGrowth as a primary academic nodal point in APAC.
Network Expansion1h ago
IP Signal
Boston, MA
Patent approved — modular mRNA delivery sequence with cold-chain independence.
IP · USPTO3h ago
Built for everyone in science
A personalized dashboard for every role in the bioeconomy.
From a PhD student with a thesis to a sovereign fund deploying billions — BioGrowth tailors onboarding, AI recommendations and tools to who you are.
ResearcherFounderStudentInvestorUniversityGovernmentIncubatorMentorNGOCompany
Founder dashboard
Welcome back, Dr. Aila
Innovation Score
92
Funding Readiness
A−
TRL
6 / 9
Mentor Matches
14
EU Horizon Europe grant — 87% matchNew
Mentor: Prof. Sato (synthetic biology)AI Pick
Pitch deck v3 generated by BioGrowth AIReady
BioGrowth AI · Always on
Upload a paper.
Get a startup.
Drop research papers, datasets or raw ideas. BioGrowth AI generates business models, market & competitor analysis, MVP roadmaps, funding matches and pitch decks — scored on commercialization readiness.
- Drag-and-drop papers, theses, datasets
- Business model, TAM/SAM/SOM and revenue maps
- MVP roadmap + AI-generated pitch deck
- Auto-matched grants, investors and mentors
BioGrowth AI
Analyzing CRISPR-X-2024.pdf
Turn this discovery into a fundable startup.
Detected a novel CRISPR delivery vector. Proposed venture:
VectraBio
Targeted gene therapy delivery · TRL 4 · Est. seed: $2.8M
94
Innovation
81
Market
76
Commercial
Six regional ecosystems
Local capital. global reach.
Country-specific grants, investors, mentors and policy updates — surfaced for you by BioGrowth AI.
Membership
Clear plans. Better decisions.
Six packages — from solo founder to sovereign institution. Pick what fits today, upgrade as your venture scales internationally.
Discover
Explore BioGrowth — draft your first BioPlan.
Free
- Read-only BioPlan templates
- 1-page pitch draft
- Community access
- 50 AI credits/mo
Starter
Solo founders & SOHO biotech heroes.
$19/mo
- Full BioPlan + financials
- Pitch builder
- Live onboarding
- 250 AI credits/mo
Most popular
Growth
Early-growth biotech SMEs scaling smart.
$49/mo
- What-if scenarios
- Dashboards & KPIs
- QuickBooks / Xero sync
- 2,000 AI credits/mo
Pro
Investor-ready biotechs closing rounds.
$99/mo
- R&D tax planning
- AI financial analysis
- Priority WhatsApp support
- 8,000 AI credits/mo
Scale
Multi-program biotechs & accelerators.
$249/mo
- BioCohort Architect
- Mentor Lab + Genome
- Donor/board reports
- 25,000 AI credits/mo
Enterprise
Universities, governments, pharma incubators.
Custom
- SAML SSO + SCIM
- Dedicated region
- DPA / BAA contracts
- Unlimited AI credits
Payments handled via WhatsApp · +20 109 613 6436 · 14-day money-back guarantee
Trust signals
Real money, real audits, real names.
Every counter on this page is wired to live data. No stock photos, no badge stickers, no fabricated logos.
LIVE · DEALS CLOSED THIS WEEK
—
Across BioGrowth-tracked rounds, last 7 days.
Capital this week
—
Disclosed amounts, founder- and partner-added.
Compliance & security
SOC 2 Type II
In progress
Audit window opens Q3 2026
GDPR
Aligned
EU data residency + DPA on request
HIPAA
BAA available
On Enterprise plan, US health-data tenants
ISO 27001
Scoping
Stage 1 audit planned Q1 2027
We publish actual audit status — never sticker badges. Request the latest SOC 2 readiness report or sign a DPA from Contact.
System status
Uptime, response times, and incident history — updated continuously.
The bioeconomy is being rewritten.
Be one of the founders.
Join thousands of scientists, founders and investors building the next wave of biotech — together, in one ecosystem.